About the Authors

Natasha Reid

n.reid@uq.edu.au

Affiliation School of Public Health, The University of Queensland, Brisbane, Australia

Robin M. Daly

Affiliation Centre for Physical Activity and Nutrition Research, Deakin University, Melbourne, Australia

Elisabeth A. H. Winkler

Affiliation School of Public Health, The University of Queensland, Brisbane, Australia

Paul A. Gardiner

Affiliations School of Public Health, The University of Queensland, Brisbane, Australia, Mater Research Institute, The University of Queensland, South Brisbane, Australia, Centre for Research in Geriatric Medicine, The University of Queensland School of Medicine, Brisbane, Australia

Elizabeth G. Eakin

Affiliation School of Public Health, The University of Queensland, Brisbane, Australia

Neville Owen

Affiliations School of Public Health, The University of Queensland, Brisbane, Australia, Baker IDI Heart and Diabetes Institute, Melbourne, Australia, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia, Department of Medicine, Alfred Hospital, Monash University, Melbourne, Australia

David W. Dunstan

Affiliations School of Public Health, The University of Queensland, Brisbane, Australia, Centre for Physical Activity and Nutrition Research, Deakin University, Melbourne, Australia, Baker IDI Heart and Diabetes Institute, Melbourne, Australia, Department of Medicine, Alfred Hospital, Monash University, Melbourne, Australia, School of Public Health & Preventive Medicine, Monash University, Melbourne, Australia, School of Sport Science, Exercise and Health, The University of Western Australia, Perth Australia

Genevieve N. Healy

Affiliations School of Public Health, The University of Queensland, Brisbane, Australia, Baker IDI Heart and Diabetes Institute, Melbourne, Australia, Mary MacKillop Institute of Health Research, Australian Catholic University, Melbourne, Australia, School of Physiotherapy, Curtin University, Perth, Australia

Competing Interests

The Australian Diabetes, Obesity and Lifestyle study (AusDiab), co-coordinated by the Baker IDI Heart and Diabetes Institute, was supported in part by Abbott Australasia Pty Ltd, Alphapharm Pty Ltd, AstraZeneca, Bristol-Myers Squibb, Eli Lilly Australia, GlaxoSmithKline, Janssen-Cilag, Merck Sharp & Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharmaceuticals, Pfizer Pty Ltd, Roche Diagnostics Australia, Sanofi Aventis and Sanofi Synthelabo. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.

Author Contributions

Conceived and designed the experiments: NO DWD RMD. Performed the experiments: NO DWD RMD. Analyzed the data: NR EAHW EGE PAG GNH. Contributed reagents/materials/analysis tools: NO DWD RMD EAHW. Wrote the paper: NR RMD EAHW PAG EGE NO DWD GNH.